Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.

May 31, 2015 | 6:30

Hilton Chicago
North International Ballroom
Chicago, Illinois

Best Practices and Emerging Treatment Strategies in the Management of Chemotherapy-Induced Nausea and Vomiting


This is an independent, accredited educational activity held adjunct to the ASCO Annual Meeting. This presentation is not sponsored or endorsed by ASCO.


Registration is complimentary. Please remember to bring your ASCO Badge. Space is limited and available on a first come first serve basis.

May 31, 2015 | 6:30pm
Hilton Chicago
North International Ballroom
Chicago, Illinois

Available seating will be based on room capacity. Seating is limited and pre-registration does not guarantee admission, as the room may be overbooked. Early arrival is recommended and seating will be first come first serve until capacity is met.


Information coming soon.


Sunday, May 31, 2015

6:30 pm

Reception and buffet dinner

7:00 pm

Welcome & Introduction

7:05 pm

Demographic and pre-session knowledge/competence polling

7:15 pm

Pathophysiology of CINV

7:35 pm

Improving Antiemetic Control: Evidence-based Guidelines and Future Therapies

7:55 pm

Panel Discussion 1: Practical Considerations in the Management of CINV

8:20 pm

Panel Discussion 2: Challenging Case Vignettes with Audience Polling

8:45 pm

Post-session knowledge/competence polling

8:50 pm

Recap of Key Points and Closing Remarks

9:00 pm


Continuing Medical Education

Imedex®, LLC is accredited by the Continuing Education Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 Credit™.

Who Should Attend

This educational activity is specifically designed for medical oncologists, oncology nurses, physician assistants, pharmacists, and other healthcare professionals involved in the management of patients with cancer.


Upon completion of these educational activities, participants should be better able to:

  • Relate the pathophysiology of CINV to rational targets for therapeutic intervention
  • Identify the risk of CINV in individual patients and monitor treatment-related acute and delayed CINV effectively for timely and effective intervention
  • Evaluate the implications of guideline-recommended best practices for the individualized management of CINV in clinical practice
  • Assess emerging clinical data on novel therapeutic approaches for the prevention and treatment of CINV and their potential role in patient management

Symposium Location

Hilton Chicago
North International Ballroom
720 South Michigan Avenue
Chicago, Illinois, 60605
USA TEL: +1-312-922-4400
FAX: +1-312-294-6891

iPad Interactive Technology

Imedex will incorporate iPad technology into this activity. Each participant will have access to an iPad that contains real-time presentation content, speaker biographies, and educational objectives. Throughout the activity, learners can use their device to answer pre/post-activity questions, vote on case discussions, and submit questions to the faculty.


The following company has provided an educational grant in support of this symposium:



11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334